Article

Analysis: Drug Costs Become Bigger Issue in Cancer Care

In the past, money was no object when cancer specialists considered which drugs would provide the best treatment for their patients.

But some top oncologists are rethinking that stance, given the soaring costs of new cancer medicines, reduced reimbursement by insurance plans and fresh research that has identified cases where cheaper generic drugs can work just as well - or better - than expensive brand-name medications.

Read the full story:

http://tinyurl.com/d2ltzp2

Source: Reuters

Related Videos
Screenshot of an interview with Evangelia Vlachou, MD
Screenshot of an interview with Barry Goy, MD
Debra Patt, MD, PhD, MBA, MPH
Clayton Irvine, PharmD, MBA, MS.
Debra Patt, MD, PhD, MBA, MPH
Debra Patt, MD, PhD, MBA, MPH
Chelsee Jensen, PharmD, BCPS.
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo